Vaalia Health

What Vaalia Health does

Vaalia Health is a privately-held health technology company that provides a patient support platform for cancer and specialty care medication management. The platform combines causal AI with human coaching to help patients stay on therapy, addressing a documented adherence gap where 20-40% of patients discontinue oral cancer medications within 100 days. The core technology is a causal AI engine built on pioneering research from SRI International, designed to identify cause-and-effect drivers of early therapy disruption rather than relying on correlation-based analytics; it supports predictive risk assessment, counterfactual intervention analysis, and integration with provider EMRs and pharmaceutical data systems. Product offerings include intelligent risk assessment, personalized medication coaching programs delivered by certified health coaches and oncology pharmacists, predictive analytics for healthcare providers, and causal insights for pharmaceutical manufacturers.

Vaalia serves a dual-sided B2B customer base: oncology clinics, hospitals, and healthcare systems on the provider side, and pharmaceutical manufacturers developing specialty medications on the pharma side. The company generates revenue through subscription-based recurring engagements with both customer types, with enterprise pricing that is not publicly disclosed. Go-to-market is primarily direct enterprise field sales, supplemented by event-driven demand generation (Slush 2025, Asembia), thought leadership content, and PR. The company was founded in 2024, raised a $2.1M seed round from Calm/Storm VC and Inventure, and formally emerged from stealth in November 2025 with operations based in Palo Alto, California and Helsinki, Finland. Current scale is approximately 12 employees plus 4 advisors.

Name

Vaalia Health

Legal name

Vaalia Health, Inc.

Website

https://vaalia.health

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Vaalia Health provides a causal AI-powered patient support platform for oncology and specialty care, combining predictive risk analytics with human coaching to improve medication adherence, sold to healthcare providers and pharmaceutical manufacturers.

Ownership category

akta.pro rank

Product category

Patient Support Software (Oncology & Specialty Care)

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372)

akta.pro primary industry

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)

akta.pro secondary industries

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

Keywords

• Patient support platform
• Causal AI healthcare
• Medication adherence
• Oncology patient care
• Specialty care services

Headquarters

HQ city

Palo Alto

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Healthcare Provider Services: Vaalia provides services to healthcare providers including tailored support programs, EMR integration, analytics for patient risk assessment, and predictive models. The company charges healthcare providers for patient support programs that improve adherence and outcomes.
2. Pharmaceutical Manufacturer Services: Services for pharma manufacturers including therapy-specific personalized support programs, clinic-integrated patient identification, multi-disciplinary coaching approach, and continuity through transitions of care. Helps address patient and provider barriers such as access and adherence.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Vaalia Health sells a Causal AI-powered patient support platform that combines software analytics with human coaching to improve medication adherence and persistence for cancer and specialty care patients. The platform integrates with healthcare providers' EMRs and pharmaceutical manufacturers' data systems to identify patients at risk of early therapy discontinuation, deliver personalized coaching programs led by certified health coaches and oncology pharmacists, and produce causal insights into treatment drivers. Customers are oncology clinics, hospitals, health systems, and pharmaceutical manufacturers who subscribe to tailored patient support programs and risk assessment services.

Product overview

Vaalia Health offers a unified patient support platform that combines causal AI with human coaching to help patients manage medications, particularly in oncology and specialty care. The core platform includes Intelligent Risk Assessment for identifying patients at risk of early discontinuation, Personalized Medication Coaching Programs delivered by certified health coaches and pharmacists, Predictive Analytics for healthcare providers, and Causal Insights and Analytics for transforming real-world data into actionable intelligence. The platform integrates directly with EMRs and pharmaceutical data systems to deliver seamless, evidence-driven patient support.

Differentiator

Problem solved

Functional benefit

Products and services

• Vaalia Health Platform A unified patient support platform combining Causal AI with human coaching to help patients manage medications in oncology and specialty care. The platform integrates with provider EMRs and pharmaceutical data systems to deliver personalized, evidence-driven patient support and analytics for risk assessment. Sold to healthcare providers (oncology clinics, hospitals, health systems) and pharmaceutical manufacturers via enterprise subscription.
• Personalized Medication Coaching Programs Virtual medication coaching programs delivered by certified health coaches and oncology pharmacists that address emotional, motivational, and clinical barriers to treatment adherence. Programs are tailored to each patient's needs and provided to healthcare providers and pharmaceutical manufacturers as a managed coaching service layered on top of the Vaalia platform.

Quantifiable outcome

• 20-40% of patients discontinue oral cancer medication within 100 days - Vaalia aims to reduce this through proactive intervention
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core and primary.

• SRI International (Stanford Research Institute)coreTechnology or Integration · 1 January 2025Vaalia Health's technology is grounded in pioneering research from SRI International, a global leader in Causal AI. Together with SRI, Vaalia's data science teams are advancing model development to bring cutting-edge AI into real-world clinical practice. The collaboration involves custom AI model development with SRI's Center for Vision Technologies team, including Yi Yao and Ajay Divakaran.
• Healthcare ProvidersprimaryStrategic or Co-development PartnerVaalia partners with healthcare providers to deliver personalized patient support and actionable insights into the patient journey. The company integrates with provider workflows and EMR systems, and is currently onboarding patients undergoing treatment for breast cancer through these partnerships.
• Pharmaceutical ManufacturersprimaryStrategic or Co-development PartnerVaalia partners with pharmaceutical manufacturers to address patient and provider barriers such as access and adherence, and strengthen patient outcomes. Services include therapy-specific personalized support programs and clinic-integrated patient identification.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Careology: Careology provides a digital cancer care platform that combines patient symptom tracking, care team coordination, and analytics for oncology providers and patients. It is a direct peer because both serve cancer patients and their care teams with technology-enabled support between visits, though Careology is UK-based and focuses on patient-facing tools.
• Medisafe: Medisafe is a medication adherence platform using digital tools, reminders, and patient engagement to improve persistence across multiple therapy areas. It is a direct peer because both address medication adherence with technology platforms, though Medisafe is therapy-agnostic and consumer-facing rather than oncology-specialized.
• Carevive Systems: Carevive builds oncology-specific patient-reported outcomes, care planning, and remote monitoring software used by cancer centers and life sciences companies. It is a direct peer because it addresses similar oncology adherence and persistence challenges with technology deployed at the provider level and supported by pharma partnerships.
• Noona Healthcare: Noona is a patient engagement platform specifically built for oncology, offering patient-reported outcomes, symptom tracking, and care team communication. It is a direct peer because Vaalia's founders came directly from Noona, and both serve oncology providers and pharma with patient support workflows, though Noona was acquired by Varian (now Siemens Healthineers).
• Navigating Cancer: Navigating Cancer provides a patient relationship management platform for oncology practices, including care plans, symptom tracking, and patient engagement tools sold to providers and pharma. It is a direct peer because both target oncology clinics with technology that improves adherence and patient-provider communication between visits.
• Memora Health: Memora Health offers an AI-powered patient engagement platform that automates clinical workflows and remote monitoring across multiple specialties, including oncology. It is a direct peer because both combine predictive analytics with patient communication to improve adherence and outcomes, though Memora is specialty-agnostic while Vaalia is oncology-focused.
• Outcomes4Me: Outcomes4Me is an AI-powered patient empowerment app focused on oncology, providing personalized treatment guidance, clinical trial matching, and patient-reported outcomes to individuals undergoing cancer treatment. It is a direct peer because it serves the same end users (cancer patients) and pharma customers with technology-enabled support, though primarily direct-to-patient rather than provider-integrated.

Broad incumbents

• Flatiron Health: Flatiron Health (acquired by Roche) provides oncology-specific electronic health records, real-world data, and analytics to community oncology practices and life sciences companies. It is a broad incumbent because it serves the same oncology provider and pharma customers with technology infrastructure, though its core product is the EHR and research-grade data, not patient support.
• Tempus Labs: Tempus is a major AI and data platform serving oncology through molecular profiling, real-world evidence, and clinical decision support sold to providers and pharma. It is a broad incumbent because it overlaps with Vaalia in oncology AI and pharma services, but operates at much larger scale with a broader portfolio including diagnostics and clinical trial services.

Emerging players

• Pack Health: Pack Health provides digital health coaching and patient engagement programs across multiple chronic conditions, including oncology, sold primarily to pharma and payors. It is an emerging player because it addresses similar adherence and self-management challenges with human coaching, but lacks Vaalia's AI-driven risk assessment and causal analytics layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/vaaliahealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vaalia Health